Brokers name 3 ASX shares to buy today

Here's why brokers are feeling bullish about these three shares this week.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

It has been another busy week for many of Australia's top brokers. This has led to the release of a number of broker notes.

Three broker buy ratings that you might want to know more about are summarised below. Here's why brokers think these ASX shares are in the buy zone right now:

Overjoyed man celebrating success with yes gesture after getting some good news on mobile.

Image source: Getty Images

Domain Holdings Australia Ltd (ASX: DHG)

According to a note out of Bell Potter, its analysts have upgraded this property listings company's shares to a buy rating with an improved price target of $3.30. This follows the release of a half year result which revealed a 27% increase in earnings per share. This was ahead of the market's expectations. The broker believes that this shows that Domain is repairing the damage to its audience and listings. It feels this could mean it is approaching the start of a potential consensus earnings upgrade cycle. The Domain share price is trading at $3.07 on Friday afternoon.

Pro Medicus Limited (ASX: PME)

Another note out of Bell Potter reveals that its analysts have upgraded this health imaging technology company's shares to a buy rating with an vastly improved price target of $330.00. This follows the release of another strong result from Pro Medicus this week. Bell Potter highlights that its full stack solution continues to wipe the floor with competitors. It notes that there have been 10 contract announcements in the last 12 months, including two new academic medical centres clients. The broker also notes that it expects further growth in the cardiology space with the first small scale implementation to take place in April. The Pro Medicus share price is fetching $284.80 at the time of writing.

Treasury Wine Estates Ltd (ASX: TWE)

Analysts at Goldman Sachs have retained their buy rating on this wine giant's shares with a slightly trimmed price target of $12.90. According to the note, the broker has reduced its sales and earnings forecasts slightly through to FY 2027 to reflect stronger Penfolds and Americas sales, offset by weaker Premium Brands sales. Outside this, Goldman points out that Treasury Wine's shares are trading on an FY 2026 P/E of just ~15x, which is inexpensive relative to its consumer coverage. And if it is able to demonstrate added comfort to the market on its Penfolds channel sell-through and sustained US luxury portfolio growth, it expects the stock to re-rate positively. The Treasury Wine share price is trading at $10.86 this afternoon.

Motley Fool contributor James Mickleboro has positions in Pro Medicus and Treasury Wine Estates. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Goldman Sachs Group. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has recommended Pro Medicus. The Motley Fool Australia has recommended Pro Medicus and Treasury Wine Estates. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

a mature but cool older woman holds a watering can and tends to a healthy green plant growing up the wall in her house.
Broker Notes

Bell Potter just initiated coverage on this ASX utilities stock with a buy recommendation

This under the radar company could be worth watching.

Read more »

Red buy button on an Apple keyboard with a finger on it.
Broker Notes

3 reasons to buy QBE shares today

A leading analyst expects QBE shares to outperform. Let’s see why.

Read more »

Broker looking at the share price.
Broker Notes

Leading brokers name 3 ASX shares to buy today

Here's why brokers believe that now could be the time to buy these shares.

Read more »

man looks at phone while disappointed
Broker Notes

What are analysts saying about ResMed, Downer, and Nuix shares?

They have given their verdicts on these shares. Are they bullish or bearish? Here's what you need to know.

Read more »

A U.S. Naval Ship (DDG) enters Sydney harbour.
Broker Notes

Why it's not too late to buy this surging ASX All Ords defence stock

A top broker expects more outperformance from this rocketing ASX defence stock.

Read more »

Businessman working and using Digital Tablet new business project finance investment at coffee cafe.
Broker Notes

Buy, hold, sell: Brainchip, CAR Group, and Endeavour shares

Let's see what analysts think about these shares this week.

Read more »

Business people discussing project on digital tablet.
Broker Notes

Buy, hold, sell: Life360, Magellan, and QBE shares

Are analysts bullish or bearish on these names? Let's find out.

Read more »

Red buy button on an Apple keyboard with a finger on it.
Broker Notes

2 ASX shares highly recommended to buy: Experts

These ASX shares are some of the most positively-rated businesses on the ASX.

Read more »